Xenon Pharmaceuticals has announced promising results from a Phase 3 clinical trial for its seizure treatment, azetukalner. The trial demonstrated a significant reduction in seizure frequency...
Gossamer Bio is set to report the results of its Phase 3 clinical trial focused on pulmonary arterial hypertension (PAH), a progressive lung disease, by the...
Gossamer Bio is preparing to announce the results of its Phase 3 clinical trial focused on treating pulmonary arterial hypertension, a serious and progressive lung disease....
Star Therapeutics has successfully secured a significant financing round, raising $125 million in its Series D funding. This investment is aimed at advancing the company’s innovative...
